Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
xjNthZfM0Hwn6a3R